These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 14733583)

  • 1. Nanogels for oligonucleotide delivery to the brain.
    Vinogradov SV; Batrakova EV; Kabanov AV
    Bioconjug Chem; 2004; 15(1):50-60. PubMed ID: 14733583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyplex Nanogel formulations for drug delivery of cytotoxic nucleoside analogs.
    Vinogradov SV; Zeman AD; Batrakova EV; Kabanov AV
    J Control Release; 2005 Sep; 107(1):143-57. PubMed ID: 16039001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and blood-brain barrier transport of [3H]-biotinylated phosphorothioate oligodeoxynucleotide conjugated to a vector-mediated drug delivery system.
    Wu D; Boado RJ; Pardridge WM
    J Pharmacol Exp Ther; 1996 Jan; 276(1):206-11. PubMed ID: 8558431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposome encapsulated polyethylenimine/ODN polyplexes for brain targeting.
    Ko YT; Bhattacharya R; Bickel U
    J Control Release; 2009 Feb; 133(3):230-7. PubMed ID: 19013203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of nanogel drug carriers and their formulations with nucleoside 5'-triphosphates.
    Vinogradov SV; Kohli E; Zeman AD
    Pharm Res; 2006 May; 23(5):920-30. PubMed ID: 16715382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted delivery of complexes of biotin-PEG-polyethylenimine and NF-kappaB decoys to brain-derived endothelial cells in vitro.
    Bhattacharya R; Osburg B; Fischer D; Bickel U
    Pharm Res; 2008 Mar; 25(3):605-15. PubMed ID: 17952570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-specific delivery of oligonucleotides to hepatocytes after systemic administration.
    Zhu L; Ye Z; Cheng K; Miller DD; Mahato RI
    Bioconjug Chem; 2008 Jan; 19(1):290-8. PubMed ID: 17850109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodistribution Analysis of NIR-Labeled Nanogels Using in Vivo FMT Imaging in Triple Negative Human Mammary Carcinoma Models.
    Gordon MR; Zhuang J; Ventura J; Li L; Raghupathi K; Thayumanavan S
    Mol Pharm; 2018 Mar; 15(3):1180-1191. PubMed ID: 29378144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery of hydrophobised 5-fluorouracil derivative to brain tissue through intravenous route using surface modified nanogels.
    Soni S; Babbar AK; Sharma RK; Maitra A
    J Drug Target; 2006 Feb; 14(2):87-95. PubMed ID: 16608735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel intracellular delivery system of antisense oligonucleotide by self-assembled hybrid micelles composed of DNA/PEG conjugate and cationic fusogenic peptide.
    Jeong JH; Kim SW; Park TG
    Bioconjug Chem; 2003; 14(2):473-9. PubMed ID: 12643759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo residence duration of human growth hormone loaded in nanogels comprising cinnamoyl alginate, cinnamoyl Pluronic F127 and cinnamoyl poly(ethylene glycol).
    Yoon DY; Kim JC
    Int J Pharm; 2016 Jul; 509(1-2):229-236. PubMed ID: 27242314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug delivery of antisense molecules to the brain for treatment of Alzheimer's disease and cerebral AIDS.
    Boado RJ; Tsukamoto H; Pardridge WM
    J Pharm Sci; 1998 Nov; 87(11):1308-15. PubMed ID: 9811482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galactose-functionalized multi-responsive nanogels for hepatoma-targeted drug delivery.
    Lou S; Gao S; Wang W; Zhang M; Zhang J; Wang C; Li C; Kong D; Zhao Q
    Nanoscale; 2015 Feb; 7(7):3137-46. PubMed ID: 25613320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymeric nanogels produced via inverse microemulsion polymerization as potential gene and antisense delivery agents.
    McAllister K; Sazani P; Adam M; Cho MJ; Rubinstein M; Samulski RJ; DeSimone JM
    J Am Chem Soc; 2002 Dec; 124(51):15198-207. PubMed ID: 12487595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo biodistribution of prion- and GM1-targeted polymersomes following intravenous administration in mice.
    Stojanov K; Georgieva JV; Brinkhuis RP; van Hest JC; Rutjes FP; Dierckx RA; de Vries EF; Zuhorn IS
    Mol Pharm; 2012 Jun; 9(6):1620-7. PubMed ID: 22536790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. iRGD-coupled responsive fluorescent nanogel for targeted drug delivery.
    Su S; Wang H; Liu X; Wu Y; Nie G
    Biomaterials; 2013 Apr; 34(13):3523-33. PubMed ID: 23410678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel lactoferrin-modified β-cyclodextrin nanocarrier for brain-targeting drug delivery.
    Ye Y; Sun Y; Zhao H; Lan M; Gao F; Song C; Lou K; Li H; Wang W
    Int J Pharm; 2013 Dec; 458(1):110-7. PubMed ID: 24126038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticle-mediated delivery of oligonucleotides to the blood-brain barrier: in vitro and in situ brain perfusion studies on the uptake mechanisms.
    Ko YT
    J Drug Target; 2013 Nov; 21(9):866-73. PubMed ID: 23952765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain.
    Shao K; Huang R; Li J; Han L; Ye L; Lou J; Jiang C
    J Control Release; 2010 Oct; 147(1):118-26. PubMed ID: 20609375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells.
    Vinogradov SV; Bronich TK; Kabanov AV
    Adv Drug Deliv Rev; 2002 Jan; 54(1):135-47. PubMed ID: 11755709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.